Fueled by aggressive marketing that hyped atypical antipsychotics as safe and effective for off-label uses, states an article in The Washington Post yesterday, sales of the drugs for off-label uses doubled from 1995 to 2008, with people seeking out antipsychotics for uses such as insomnia. Sales of antipsychotics as a class rose more than 169% between 2001 and 2010, making them one of the best-selling drugs; ahead of antidepressants and sometimes cholesterol medications.
Article → Discuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.